PRINCETON, N.J. & REHOVOT, Israel--(BUSINESS WIRE)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces the posting of the following Letter to Shareholders from President and Chief Executive Officer Kenneth A. Berlin to the Investors section of the Company’s website at www.rosettagenomics.com.
Dear Fellow Shareholders:
As we begin the New Year, I would like to express my appreciation to all our shareholders for the trust and support you have given Rosetta Genomics as we continue to build upon our microRNA platform technology to strengthen our leading position in the growing field of molecular diagnostics and genomics.
Help employers find you! Check out all the jobs and post your resume.
